Veterinary Medicines

Erysin Single Shot Emulsja do wstrzykiwań

Authorised
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-64, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-5, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-II, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 1, strain 1-203, Inactivated
Download as PDF

Product identification

Medicine name:
Erysin Single Shot Emulsja do wstrzykiwań
Active substance:
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-64, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-5, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-II, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 1, strain 1-203, Inactivated
Target species:
  • Pig
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-64, Inactivated
    1.00
    relative potency
    /
    1.00
    relative potency
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-5, Inactivated
    1.00
    relative potency
    /
    1.00
    relative potency
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-II, Inactivated
    1.00
    relative potency
    /
    1.00
    relative potency
  • Erysipelothrix rhusiopathiae, serotype 1, strain 1-203, Inactivated
    1.00
    relative potency
    /
    1.00
    relative potency
Pharmaceutical form:
  • Emulsion for injection/infusion
Withdrawal period by route of administration:
  • Subcutaneous use
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Available in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Grabikowski-Grabikowska Przedsiebiorstwo Produkcyjno-Handlowo-Uslugowe Inex Sp. j.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 2110
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 25/04/2025
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 21/08/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 8/12/2025
Download